NYSE:LCTX | ROE | Lineage Cell Therapeutics, Inc.

Complete source-backed roe history.

Available history
2009-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-52.96%
2026-03-31-119.18%
2025-12-31-142.61%
2025-09-30-306.97%
2025-06-30-84.55%
2025-03-31-20.51%
2024-12-31-23.74%
2024-09-30-30.39%
2024-06-30-35.41%
2024-03-31-32.67%
2023-12-31-33.88%
2023-09-30-33.86%
2023-06-30-30.31%
2023-03-31-33.44%
2022-12-31-35.82%
2022-09-30-61.95%
2022-06-30-61.15%
2022-03-31-56.26%
2021-12-31-46.65%
2021-09-30-9.94%
2021-06-30-9.57%
2021-03-31-11.61%
2020-12-31-21.46%
2020-09-30-29.76%
2020-06-30-36.11%
2020-03-31-55.79%
2019-12-31-10.37%
2019-09-30-44.54%
2019-06-3023.28%
2019-03-3135.27%
2018-12-31-49.86%
2018-09-30-42.64%
2018-06-30-124.16%
2018-03-31-132.85%
2017-12-31-12.28%
2017-09-3023.64%
2017-06-3036.20%
2017-03-3153.35%
2016-12-3128.46%
2016-09-3021.12%
2016-06-30-22.87%
2016-03-31-496.25%
2015-12-31-181.70%
2015-09-30-337.87%
2015-06-30-227.99%
2015-03-31-146.81%
2014-12-31-100.04%
2014-09-30-414.33%
2014-06-30-258.12%
2014-03-31-230.03%
2013-12-31-296.50%
2013-09-30-234.21%
2013-06-30-125.56%
2013-03-31-152.54%
2012-12-31-223.52%
2012-09-30-122.49%
2012-06-30-84.26%
2012-03-31-75.83%
2011-12-31-58.43%
2011-09-30-42.67%
2011-06-30-42.28%

Annual ROE

DateROE
2025-12-31-142.61%
2024-12-31-23.74%
2023-12-31-33.88%
2022-12-31-35.82%
2021-12-31-46.65%
2020-12-31-21.46%
2019-12-31-10.37%
2018-12-31-49.01%
2017-12-31-12.28%
2016-12-3128.47%
2015-12-31-182.02%
2014-12-31-99.88%
2013-12-31-296.49%
2012-12-31-223.54%
2011-12-31-57.65%
2010-12-31-29.30%
2009-12-31-46.57%